Acasă › Cancer pancreatic › California › Irvine
Studii clinice pentru Cancer pancreatic în Irvine, CA
10 studii pentru Cancer pancreatic caută participanți în și în jurul orașului Irvine (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
În curs de recrutareFaza 1
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- City of Hope at Irvine Lennar, Irvine
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
În curs de recrutareFaza 1
- City of Hope at Irvine Lennar, Irvine
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
În curs de recrutareFaza 2/3
- Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UCI Health - Irvine, Irvine
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
În curs de recrutareFaza 3
- UCI Health - Irvine, Irvine
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
În curs de recrutareFaza 1
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
În curs de recrutareFaza 1/2
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- City of Hope at Irvine Lennar, Irvine
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
În curs de recrutareFaza 3
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.
În curs de recrutareFaza 1/2
- CIty of Hope, Irvine
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
În curs de recrutareFaza 1
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 278589, Irvine
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Irvine
Studii pentru Cancer pancreatic în alte orașe
- Houston, TX61 studii
- New York City, NY60 studii
- Boston, MA43 studii
- Nashville, TN39 studii
- Los Angeles, CA35 studii
- St. Louis, MO33 studii
- Arlington, VA33 studii
- Baltimore, MD31 studii
- San Antonio, TX31 studii
- Philadelphia, PA26 studii
- Tampa, FL26 studii
- Durham, NC24 studii
Alte studii în Irvine
- Cancer pulmonar cu celule non-pătrate25 studii
- Cancer de sân23 studii
- Cancer (toate tipurile)17 studii
- Cancer metastatic16 studii
- Cancer pulmonar15 studii
- Mielom multiplu14 studii
- Cancer de prostată14 studii
- Cancer ovarian12 studii
- Carcinom cu celule scuamoase de cap și gât11 studii
- Cancer de vezică urinară11 studii
- Boala Alzheimer11 studii
- Cancer colorectal10 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.